Showing results (81-90 of 288) with videos related to

Sort By:
Pageof 29
The Journal of Urology|February 10, 2004
Cytoreductive nephrectomy in patients with metastatic renal cancer: a combined analysisRobert C Flanigan, G Mickisch, Richard Sylvester, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|April 11, 2013
Review of the economic evaluations of hormonal therapy for patients with locally advanced prostate cancerHind T Hatoum, E David Crawford, Sandy Kildegaard Nielsen, et al.
Urologic Oncology|January 14, 2011
Phase II evaluation of doxorubicin/vinblastine combined with inhibitors trifluoperazine/verapamil of P-glycoprotein in patients with advanced renal carcinomaL E Schroder, B A Blumenstein, R L Flanigan, et al.
The Journal of Urology|November 13, 2004
Prognostic value of anemia in newly diagnosed metastatic prostate cancer: a multivariate analysis of southwest oncology group study 8894Tomasz M Beer, Catherine M Tangen, Lisa B Bland, et al.
Therapeutic Advances in Medical Oncology|May 23, 2017
Abiraterone acetate and prednisone in chemotherapy-naïve prostate cancer patients: rationale, evidence and clinical utilityE David Crawford, Neal D Shore, Daniel P Petrylak, et al.
Cancer Research|September 18, 2002
The possible role of postoperative azotemia in enhanced survival of patients with metastatic renal cancer after cytoreductive nephrectomyRobert A Gatenby, Edward T Gawlinski, Catherine M Tangen, et al.
BJU International|August 2, 2006
Trends and predictors of aggressive therapy for clinical locally advanced prostate carcinomaThomas D Denberg, L Michael Glodé, John F Steiner, et al.
BJU International|July 6, 2013
The utility of prostate-specific antigen in the management of advanced prostate cancerE David Crawford, Charles L Bennett, Gerald L Andriole, et al.
American Journal of Men'S Health|June 17, 2015
Effects of Testosterone Level on Lower Urinary Tract SymptomsE David Crawford, Wendy Poage, Allen Nyhuis, et al.
The Journal of Urology|December 23, 2008
Predictors of survival of advanced renal cell carcinoma: long-term results from Southwest Oncology Group Trial S8949Primo N Lara, Catherine M Tangen, Sarah J Conlon, et al.
Pageof 29